Abstract

This article analyzes the challenges faced by regulators in the European Union when dealing with nanotechnology. By examining the status quo of nanospecific regulation as well as current proposals for future legislation, the article shows the difficulty of adapting the main regulatory tool – the precautionary principle – to challenges in areas such as chemicals, novel food, cosmetics, medical devices or biocides. Designed to work in areas in which there is only a very limited knowledge base, regulators are forced to apply the precautionary principle in a way that achieves a balance between the protection of human health and the environment, on the one hand, and the promotion of wealth and technological progress, on the other.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call